Polyunsaturated Fatty Acids and Cardiovascular Disease: Implications for Nutrigenetics
- 23 September 2009
- journal article
- review article
- Published by S. Karger AG in Lifestyle Genomics
- Vol. 2 (3), 140-148
- https://doi.org/10.1159/000235562
Abstract
Cardiovascular disease (CVD) arises as a result of genetic predisposition in the context of a disease-promoting environment. While several risk factors have been identified for CVD, such as elevated serum lipid levels and hypertension, most of the genes identified thus far do not appear to involve such ‘conventional’ risk factors. Moreover, the interactions between genes and environment, such as a diet high in certain fats, adds another level of complexity to CVD and renders identification of the underlying genetic factors even more difficult. Polyunsaturated fatty acids (PUFAs), such as the ω–6 and ω–3 fatty acids, which have multiple roles in membrane structure, lipid metabolism, blood clotting, blood pressure, and, in particular, inflammation, have been linked to the reduction in CVD. Linoleic (ω–6) and α-linolenic acid (ω–3) are essential fatty acids that can be converted into long-chain PUFAs, such as arachidonic acid (AA) and eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA), respectively. These long-chain PUFAs are metabolized by enzymatically catalyzed systems via cyclooxygenases and lipoxygenases. The 5-lipoxygenase (5-LO)/leukotriene (LT) biosynthesis pathway has been biochemically and genetically associated with CVD traits in mice and humans, particularly in the context of dietary AA and EPA/DHA. In this review, we summarize the biochemical metabolism of ω–3 and ω–6 PUFAs, evaluate the evidence for genetic and nutrigenetic contributions of 5-LO pathway genes to CVD, and discuss the potential of future studies that could identify other gene-dietary interactions between PUFAs and CVD traits.Keywords
This publication has 67 references indexed in Scilit:
- Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacologyPharmacology & Therapeutics, 2008
- Identification of ALOX5 as a gene regulating adiposity and pancreatic functionDiabetologia, 2008
- Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery diseaseHuman Genetics, 2008
- Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in MiceCirculation Research, 2002
- Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Efficiency of conversion of α-linolenic acid to long chain n-3 fatty acids in manCurrent Opinion in Clinical Nutrition and Metabolic Care, 2002
- The Biochemistry of n-3 Polyunsaturated Fatty AcidsPublished by Elsevier BV ,2002
- Genetic Locus in Mice That Blocks Development of Atherosclerosis Despite Extreme HyperlipidemiaCirculation Research, 2001
- AtherosclerosisNature, 2000
- Intracellular Compartmentalization of Leukotriene BiosynthesisAmerican Journal of Respiratory and Critical Care Medicine, 2000